Search Page

1

Cite

Share

GeneXpert for TB diagnosis: planned and purposeful implementation.

Piatek AS, Van Cleeff M, Alexander H, Coggin WL, Rehr M, Van Kampen S, Shinnick TM, Mukadi Y. Piatek AS, et al. Glob Health Sci Pract. 2013 Mar 21;1(1):18-23. doi: 10.9745/GHSP-D-12-00004. eCollection 2013 Mar. Glob Health Sci Pract. 2013. PMID: 25276513 Free PMC article. Review.

Cite

Share

2

Cite

Share

Rolling Out Xpert^® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems Strengthening.

Pathmanathan I, Date A, Coggin WL, Nkengasong J, Piatek AS, Alexander H. Pathmanathan I, et al. Among authors: piatek as. Afr J Lab Med. 2017 Mar 31;6(2):460. doi: 10.4102/ajlm.v6i2.460. Afr J Lab Med. 2017. PMID: 28785533 Free PMC article.

Cite

Share

3

Cite

Share

Realizing the "40 by 2022" Commitment from the United Nations High-Level Meeting on the Fight to End Tuberculosis: What Will It Take to Meet Rapid Diagnostic Testing Needs?

Piatek AS, Wells WA, Shen KC, Colvin CE. Piatek AS, et al. Glob Health Sci Pract. 2019 Dec 23;7(4):551-563. doi: 10.9745/GHSP-D-19-00244. Print 2019 Dec 23. Glob Health Sci Pract. 2019. PMID: 31818871 Free PMC article.

Cite

Share

4

Cite

Share

Missed opportunities for tuberculosis prevention in New York City, 2003.

Slopen ME, Laraque F, Piatek AS, Ahuja SD. Slopen ME, et al. Among authors: piatek as. J Public Health Manag Pract. 2011 Sep-Oct;17(5):421-6. doi: 10.1097/PHH.0b013e31820759b8. J Public Health Manag Pract. 2011. PMID: 21788779

Cite

Share

5

Cite

Share

Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study.

Law S, Piatek AS, Vincent C, Oxlade O, Menzies D. Law S, et al. Among authors: piatek as. Lancet Public Health. 2017 Jan;2(1):e47-e55. doi: 10.1016/S2468-2667(16)30035-4. Epub 2016 Dec 19. Lancet Public Health. 2017. PMID: 29249480 Free article.

Cite

Share

6

Cite

Share

Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis.

Rhee JT, Piatek AS, Small PM, Harris LM, Chaparro SV, Kramer FR, Alland D. Rhee JT, et al. Among authors: piatek as. J Clin Microbiol. 1999 Jun;37(6):1764-70. doi: 10.1128/JCM.37.6.1764-1770.1999. J Clin Microbiol. 1999. PMID: 10325321 Free PMC article.

Cite

Share

7

Cite

Share

Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis.

Piatek AS, Tyagi S, Pol AC, Telenti A, Miller LP, Kramer FR, Alland D. Piatek AS, et al. Nat Biotechnol. 1998 Apr;16(4):359-63. doi: 10.1038/nbt0498-359. Nat Biotechnol. 1998. PMID: 9555727

Cite

Share

8

Cite

Share

Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.

Piatek AS, Telenti A, Murray MR, El-Hajj H, Jacobs WR Jr, Kramer FR, Alland D. Piatek AS, et al. Antimicrob Agents Chemother. 2000 Jan;44(1):103-10. doi: 10.1128/AAC.44.1.103-110.2000. Antimicrob Agents Chemother. 2000. PMID: 10602730 Free PMC article.

Cite

Share

9

Cite

Share

Universal genotyping in tuberculosis control program, New York City, 2001-2003.

Clark CM, Driver CR, Munsiff SS, Driscoll JR, Kreiswirth BN, Zhao B, Ebrahimzadeh A, Salfinger M, Piatek AS, Abdelwahab J. Clark CM, et al. Among authors: piatek as. Emerg Infect Dis. 2006 May;12(5):719-24. doi: 10.3201/eid1205.050446. Emerg Infect Dis. 2006. PMID: 16704826 Free PMC article.

Cite

Share

10

Cite

Share

Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.

Schito M, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW. Schito M, et al. Among authors: piatek as. J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S169-80. doi: 10.1093/infdis/jis044. Epub 2012 Mar 29. J Infect Dis. 2012. PMID: 22457286 Free PMC article.

Cite

Share